相关实验视频

Updated: Apr 23, 2026

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds

Published on: August 16, 2014

基于凝电旋膜的可控双重药物递送系统,用于促进伤口愈合

Fen Ao¹, Changyu Yin¹, Xiaomin Luo¹

¹College of Bioresources Chemical and Materials Engineering, Institute of Biomass & Functional Materials, Shaanxi University of Science &Technology, Xi'an 710021, PR China.

International journal of biological macromolecules

|December 18, 2024

概括

这项研究引入了一种新的双药物递送系统 (PGDMD),可以智能地释放奎尔素和阿米卡,以改善皮肤伤口的修复. 该系统利用电场刺激来控制释放和减少炎症,提高治疗结果.

科学领域:

生物材料科学生物材料科学
药物输送系统药物输送系统
伤口治愈研究研究伤口治愈研究

背景情况:

目前的双重药物输送系统缺乏适应复杂的伤口愈合过程的适应性.
需要智能,响应和可控制的药物释放系统来理解和增强伤口修复机制.

研究的目的:

设计和评估一种新的基于凝的双重药物递送系统 (PGDMD),具有电场刺激的受控释放.
研究药物释放动力学和PGDMD对皮肤伤口修复的体内治疗效果.

主要方法:

制造一种基于凝的双重药物输送系统 (PGDMD).
在电场刺激下进行体外药物释放研究.
对PGDMD对老鼠创伤性皮肤的影响进行非向代谢学分析.
评估炎症和氧化应激反应.

主要成果:

在药物释放过程中,PGDMD从纤维膜过渡到凝状态.
奎尔塞丁在60分钟内呈现出快速释放;阿米卡辛在24小时内释放.
电场刺激通过静电作用加速药物释放.
在老鼠中,PGDMD通过调节抗氧化代谢物升级来降低炎症和氧化应激,改善皮肤修复.

结论:

该PGDMD系统展示了智能,可控释放能力,用于双重药物输送.
该系统通过调节炎症和氧化应激路径,有效增强皮肤伤口修复.
PGDMD显示出在医疗器械和制药领域的应用潜力,为生物材料与生物体相互作用提供了洞察力.

关键词:

双重的药物输送系统.凝是什么意思凝是什么意思伤口愈合伤口愈合

更多相关视频

Wet-spinning-based Molding Process of Gelatin for Tissue Regeneration

Wet-spinning-based Molding Process of Gelatin for Tissue Regeneration

Published on: March 7, 2019

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

相关概念视频

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...